UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The EANM practice guidelines for parathyroid imaging

European journal of nuclear medicine and molecular imaging, 2021-08, Vol.48 (9), p.2801-2822

2021

Volltextzugriff (PDF)

Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group

The lancet oncology, 2018-10, Vol.19 (10), p.e534-e545

2018

Volltextzugriff (PDF)

68Ga-PSMA-11 PET/CT in restaging castration-resistant nonmetastatic prostate cancer: detection rate, impact on patients’ disease management and adequacy of impact

Scientific reports, 2020-02, Vol.10 (1), p.2104-2104, Article 2104

2020

Volltextzugriff (PDF)

18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study

European journal of nuclear medicine and molecular imaging, 2016-10, Vol.43 (11), p.1995-2004

2016

Volltextzugriff (PDF)

Hepatocellular Carcinomas With Mutational Activation of Beta-Catenin Require Choline and Can Be Detected by Positron Emission Tomography

Gastroenterology (New York, N.Y. 1943), 2019-09, Vol.157 (3), p.807-822

2019

Volltextzugriff (PDF)

Liposomes for PET and MR Imaging and for Dual Targeting (Magnetic Field/Glucose Moiety): Synthesis, Properties, and in Vivo Studies

Molecular pharmaceutics, 2017-02, Vol.14 (2), p.406-414

2017

Volltextzugriff (PDF)

An essential practice summary of the new EANM guidelines for parathyroid imaging

The quarterly journal of nuclear medicine and molecular imaging, 2022-06, Vol.66 (2), p.93

2022

Volltextzugriff (PDF)

Editorial Comment: Advances in MRI and PET of the prostate: concurrence or complementarity?

European radiology, 2018-08, Vol.28 (8), p.3138-3140

2018

Volltextzugriff (PDF)

[68Ga]RGD Versus [18F]FDG PET Imaging in Monitoring Treatment Response of a Mouse Model of Human Glioblastoma Tumor with Bevacizumab and/or Temozolomide

Molecular imaging and biology, 2019-04, Vol.21 (2), p.297-305

2019

Volltextzugriff (PDF)

A comparative study of peptide-based imaging agents [68Ga]Ga-PSMA-11, [68Ga]Ga-AMBA, [68Ga]Ga-NODAGA-RGD and [68Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models

Nuclear medicine and biology, 2020-05, Vol.84-85, p.88-95

2020

Volltextzugriff (PDF)

18F-fluorocholine PET/CT in MEN1 Patients with Primary Hyperparathyroidism

World journal of surgery, 2020-11, Vol.44 (11), p.3761-3769

2020

Volltextzugriff (PDF)

Fully automated radiolabeling of [68Ga]Ga-EMP100 targeting c-MET for PET-CT clinical imaging

EJNMMI radiopharmacy and chemistry, 2023-10, Vol.8 (1), p.30-30, Article 30

2023

Volltextzugriff (PDF)

Current evaluation of the clinical utility of Fluoromethylcholine-(18F) PET/CT in Prostate Cancer

Brazilian Archives of Biology and Technology, 2008-12, Vol.51 (spe), p.71-75

2008

Volltextzugriff (PDF)

Novel DOTA-Neurotensin Analogues for 111In Scintigraphy and 68Ga PET Imaging of Neurotensin Receptor-Positive Tumors

Bioconjugate chemistry, 2011-07, Vol.22 (7), p.1374-1385

2011

Volltextzugriff (PDF)

Equivalent Dose Rate 1 Meter from Neuroendocrine Tumor Patients Exiting the Nuclear Medicine Department After Undergoing Imaging

Journal of Nuclear Medicine, 2017-08, Vol.58 (8), p.1230-1235

2017

Volltextzugriff (PDF)

Can Fluorodihydroxyphenylalanine PET Replace Somatostatin Receptor Scintigraphy in Patients with Digestive Endocrine Tumors?

The Journal of nuclear medicine (1978), 2006-09, Vol.47 (9), p.1455-1462

2006

Volltextzugriff (PDF)

Impact of Fluorodihydroxyphenylalanine-(18F) Positron Emission Tomography on Management of Adult Patients with Documented or Occult Digestive Endocrine Tumors

The journal of clinical endocrinology and metabolism, 2009-04, Vol.94 (4), p.1295-1301

2009

Volltextzugriff (PDF)

Positron Emission Tomography/Computed Tomography Imaging of Residual Skull Base Chordoma Before Radiotherapy Using Fluoromisonidazole and Fluorodeoxyglucose: Potential Consequences for Dose Painting

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.681-687

2012

Volltextzugriff (PDF)

PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT

European journal of nuclear medicine and molecular imaging, 2006-11, Vol.33 (11), p.1285-1289

2006

Volltextzugriff (PDF)

Impact of FDG PET/CT in the staging and the follow-up of anal carcinoma

International journal of colorectal disease, 2011-02, Vol.26 (2), p.201-210

2011

Volltextzugriff (PDF)

Incidental uptake of 18F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer

Radiology and oncology, 2014-09, Vol.48 (3), p.228-234

2014

Volltextzugriff (PDF)

Comparison of Normocalcemic vs Hypercalcemic Primary Hyperparathyroidism in a Hypercalciuric Renal Stone Population

The journal of clinical endocrinology and metabolism, 2024-09, Vol.109 (10), p.2553-2560

2024

Volltextzugriff (PDF)

Nuclear medicine innovations help (drive) healthcare (benefits)

European journal of nuclear medicine and molecular imaging, 2015-02, Vol.42 (2), p.173-175

2015

Volltextzugriff (PDF)

Response to the letter to the Editor by Professors Francesco Giammarile and Stefano Fanti regarding our article “Survey by the ANSM of the imaging protocol, detection rate, and safety of 68Ga-PSMA-11 PET/CT”

European journal of nuclear medicine and molecular imaging, 2021-08, Vol.48 (9), p.2692-2695

2021

Volltextzugriff (PDF)

Interference of Known or Suspected Endometriosis in Reporting FDG PET/CT Performed in Another Indication

Clinical nuclear medicine, 2022-04, Vol.47 (4), p.305-313

2022

Volltextzugriff (PDF)

1 – 25 von 190

Suche als RSS-Feed

Aktive Filter

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(163)

Publikationsform

Artikel
(190)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(84)
Science & Technology
(68)
Life Sciences & Biomedicine
(66)
Female
(48)
Male
(47)
Radiopharmaceuticals
(42)
Fluorodeoxyglucose F18
(41)
Middle Aged
(40)
Aged
(34)
Radiology, Nuclear Medicine & Medical Imaging
(33)
Adult
(29)
Positron-Emission Tomography
(26)
Nuclear Medicine
(24)
Oncology
(22)
Tomography
(22)
Imaging
(21)
Medicine
(21)
Positron-Emission Tomography - Methods
(21)
Radiology
(21)
Life Sciences
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

The EANM practice guidelines for parathyroid imaging

Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group

68Ga-PSMA-11 PET/CT in restaging castration-resistant nonmetastatic prostate cancer: detection rate, impact on patients’ disease management and adequacy of impact

18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study

Hepatocellular Carcinomas With Mutational Activation of Beta-Catenin Require Choline and Can Be Detected by Positron Emission Tomography

Liposomes for PET and MR Imaging and for Dual Targeting (Magnetic Field/Glucose Moiety): Synthesis, Properties, and in Vivo Studies

An essential practice summary of the new EANM guidelines for parathyroid imaging

Editorial Comment: Advances in MRI and PET of the prostate: concurrence or complementarity?

[68Ga]RGD Versus [18F]FDG PET Imaging in Monitoring Treatment Response of a Mouse Model of Human Glioblastoma Tumor with Bevacizumab and/or Temozolomide

A comparative study of peptide-based imaging agents [68Ga]Ga-PSMA-11, [68Ga]Ga-AMBA, [68Ga]Ga-NODAGA-RGD and [68Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models

18F-fluorocholine PET/CT in MEN1 Patients with Primary Hyperparathyroidism

Fully automated radiolabeling of [68Ga]Ga-EMP100 targeting c-MET for PET-CT clinical imaging

Current evaluation of the clinical utility of Fluoromethylcholine-(18F) PET/CT in Prostate Cancer

Novel DOTA-Neurotensin Analogues for 111In Scintigraphy and 68Ga PET Imaging of Neurotensin Receptor-Positive Tumors

Equivalent Dose Rate 1 Meter from Neuroendocrine Tumor Patients Exiting the Nuclear Medicine Department After Undergoing Imaging

Can Fluorodihydroxyphenylalanine PET Replace Somatostatin Receptor Scintigraphy in Patients with Digestive Endocrine Tumors?

Impact of Fluorodihydroxyphenylalanine-(18F) Positron Emission Tomography on Management of Adult Patients with Documented or Occult Digestive Endocrine Tumors

Positron Emission Tomography/Computed Tomography Imaging of Residual Skull Base Chordoma Before Radiotherapy Using Fluoromisonidazole and Fluorodeoxyglucose: Potential Consequences for Dose Painting

PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT

Impact of FDG PET/CT in the staging and the follow-up of anal carcinoma

Incidental uptake of 18F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer

Comparison of Normocalcemic vs Hypercalcemic Primary Hyperparathyroidism in a Hypercalciuric Renal Stone Population

Nuclear medicine innovations help (drive) healthcare (benefits)

Response to the letter to the Editor by Professors Francesco Giammarile and Stefano Fanti regarding our article “Survey by the ANSM of the imaging protocol, detection rate, and safety of 68Ga-PSMA-11 PET/CT”

Interference of Known or Suspected Endometriosis in Reporting FDG PET/CT Performed in Another Indication

Aktive Filter

Suchergebnisse filtern